Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fujian Cancer Hospital
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
Ipsen
M.D. Anderson Cancer Center
Yonsei University
M.D. Anderson Cancer Center
Massachusetts General Hospital
Gruppo Oncologico Italiano di Ricerca Clinica
Hoffmann-La Roche
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Jinling Hospital, China
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Oklahoma
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of California, San Francisco
Hoosier Cancer Research Network
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Hoffmann-La Roche
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
Sun Yat-sen University
Sun Yat-sen University
Leiden University Medical Center
Dana-Farber Cancer Institute
Assistance Publique - Hôpitaux de Paris
ImmunityBio, Inc.
Memorial Sloan Kettering Cancer Center
NRG Oncology
Centre Francois Baclesse
M.D. Anderson Cancer Center
Emory University
City of Hope Medical Center
Sun Yat-sen University
M.D. Anderson Cancer Center
RenJi Hospital
M.D. Anderson Cancer Center
Mayo Clinic